Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

Govt Reaffirms NPPA Stent Price Caps, States Tasked With Curbing Hospital Overcharging

Parthika Patel16 Feb 2026 4:33 PM IST

New Delhi: The Government has clarified that coronary stents are under price control and private hospitals are required to comply with the notified...

Alkem's Enzene Unit Gets 6 USFDA Observations

Parthika Patel16 Feb 2026 3:30 PM IST

New Delhi: Alkem Laboratories Limited has announced that the United States Food and Drug Administration (USFDA) has completed a Pre-Approval...

Zydus Secures Final USFDA Approval for Ammonium Lactate Cream, Expands Generics Basket

Parthika Patel16 Feb 2026 3:22 PM IST

New Delhi: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Ammonium Lactate...

Jubilant Pharmova's Canada Plant Gets USFDA OAI Status, Remediation Underway

Parthika Patel16 Feb 2026 3:13 PM IST

New Delhi: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has classified its contract...

47 Drug Inspectors for 2.5 Lakh Batches: Kerala Faces Oversight Strain

Parthika Patel15 Feb 2026 1:30 PM IST

Thiruvananthapuram: Despite having an annual pharmaceutical market valued at nearly Rs15,000 crore, Kerala currently has only 47 drug inspectors...

Pharmacy Trader Loses Rs 6.7 Crore to Fake Investment App Fraud

Parthika Patel15 Feb 2026 1:00 PM IST

Kolhapur: A 52-year-old wholesale pharmacy distributor from Karad has lost Rs 6.7 crore over a period of six months after falling prey to a...

Pharma Plant Destroyed in Massive Choutuppal Explosion

Parthika Patel14 Feb 2026 9:32 PM IST

Nalgonda: A devastating explosion tore through a pharmaceutical manufacturing facility late on Friday night at Brindavan Labs, situated on the...

Natco Pharma's Generic Semaglutide to Hit Indian Market in March

Parthika Patel14 Feb 2026 9:26 PM IST

New Delhi: Natco Pharma Limited has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market...

USFDA Concludes PAI at Cipla Subsidiary InvaGen With 2 Observations

Parthika Patel13 Feb 2026 12:30 PM IST

New Delhi: Cipla Limited has informed the stock exchanges that the United States Food and Drug Administration (USFDA) conducted a Pre-Approval...

USFDA Issues 9 Observations to Aurobindo's Jedcherla Unit-VII After Inspection

Parthika Patel12 Feb 2026 11:44 PM IST

New Delhi: Aurobindo Pharma Limited recently informed that the United States Food and Drug Administration (USFDA) has completed an inspection at its...

GST Probe at Mankind Pharma's BSV Unit in Mumbai

Parthika Patel12 Feb 2026 11:36 PM IST

New Delhi: Mankind Pharma Limited has informed the stock exchanges that the Goods and Services Tax (GST) Department, Mumbai, carried out a search and...

OneSource Wins Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout

OneSource Secures Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout

Parthika Patel12 Feb 2026 11:26 PM IST

New Delhi: OneSource Specialty Pharma Limited has received regulatory approval in Saudi Arabia to commercialise a generic version of Ozempic...

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok